TB-500 vs DSIP
A comprehensive, data-driven comparison of TB-500 (Thymosin Beta-4) and DSIP (Delta Sleep-Inducing Peptide). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | TB-500 Thymosin Beta-4, Tβ4 | DSIP Delta Sleep-Inducing Peptide |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | Category 2 |
| Category | Recovery & Healing | Sleep |
| Primary Use | Tissue repair and injury recovery | Sleep disorders and stress reduction |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $40 - $80/mo | $35 - $70/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 2-5mg twice weekly | 100-300mcg before bed |
| Frequency | Twice weekly | Daily |
| Mechanism | Synthetic version of thymosin beta-4 that promotes cell migration, reduces inflammation, and accelerates wound healing | Neuropeptide that may modulate sleep patterns, reduce stress, and regulate circadian rhythms |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Low | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1DSIP is generally more affordable ($35 - $70/mo) compared to TB-500 ($40 - $80/mo).
- 2TB-500 is dosed twice weekly, while DSIP is daily.
- 3TB-500 has low-quality evidence, while DSIP has emerging-quality evidence.
- 4They belong to different categories: TB-500 (Recovery & Healing) vs DSIP (Sleep).
Which Is Better For...
DSIP
More budget-friendly option with lower monthly costs
TB-500
More convenient dosing schedule (twice weekly)
TB-500
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| TB-500 | $40 - $80/mo | Category 2 (pending reclassification) | Various research labs |
| DSIP | $35 - $70/mo | Category 2 | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
TB-500 works via Synthetic version of thymosin beta-4 that promotes cell migration, reduces inflammation, and. DSIP works via Neuropeptide that may modulate sleep patterns, reduce stress, and regulate circadian rhythms. They differ in FDA approval status, efficacy data, and cost.
TB-500 typically costs $40 - $80/mo, while DSIP costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
TB-500 is not FDA-approved (Category 2 (pending reclassification)). DSIP is not FDA-approved (Category 2). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of TB-500 include Injection site reactions, Mild fatigue, Headache. Common side effects of DSIP include Injection site reactions, Drowsiness, Vivid dreams. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4, which plays a crucial role in tissue repair and regeneration. It promotes the migration of endothelial and keratinocyt...
View Full TB-500 GuideDSIP (Delta Sleep-Inducing Peptide) is a neuropeptide first discovered in 1977 in the brains of sleeping rabbits. Research suggests it may have broader effects on stress response, pain modulation, and...
View Full DSIP GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between TB-500 and DSIP should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.